These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 29298604)

  • 61. Evaluation of the statistical power for multiple tests: a case study.
    Yeo A; Qu Y
    Pharm Stat; 2009; 8(1):5-11. PubMed ID: 18381588
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Simple procedures for blinded sample size adjustment that do not affect the type I error rate.
    Kieser M; Friede T
    Stat Med; 2003 Dec; 22(23):3571-81. PubMed ID: 14652861
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Group sequential t-test for clinical trials with small sample sizes across stages.
    Shao J; Feng H
    Contemp Clin Trials; 2007 Sep; 28(5):563-71. PubMed ID: 17434814
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Improving sample size recalculation in adaptive clinical trials by resampling.
    Herrmann C; Kluge C; Pilz M; Kieser M; Rauch G
    Pharm Stat; 2021 Nov; 20(6):1035-1050. PubMed ID: 33792167
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cost-efficient designs for three-arm trials with treatment delivered by health professionals: Sample sizes for a combination of nested and crossed designs.
    Moerbeek M
    Clin Trials; 2018 Apr; 15(2):169-177. PubMed ID: 29316807
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Internal pilots for a class of linear mixed models with Gaussian and compound symmetric data.
    Gurka MJ; Coffey CS; Muller KE
    Stat Med; 2007 Sep; 26(22):4083-99. PubMed ID: 17318914
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Factorial designs: a graphical aid for choosing study designs accounting for interaction.
    Byth K; Gebski V
    Clin Trials; 2004; 1(3):315-25. PubMed ID: 16279257
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Exact critical values for group sequential designs with small sample sizes.
    Rom DM; McTague JA
    J Biopharm Stat; 2020 Jul; 30(4):752-764. PubMed ID: 32151177
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Sample-size calculation and reestimation for a semiparametric analysis of recurrent event data taking robust standard errors into account.
    Ingel K; Jahn-Eimermacher A
    Biom J; 2014 Jul; 56(4):631-48. PubMed ID: 24817598
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Evaluating the adaptive performance of flexible sample size designs with treatment difference in an interval.
    Liu GF; Zhu GR; Cui L
    Stat Med; 2008 Feb; 27(4):584-96. PubMed ID: 17634972
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The role of internal pilot studies in increasing the efficiency of clinical trials.
    Wittes J; Brittain E
    Stat Med; 1990; 9(1-2):65-71; discussion 71-2. PubMed ID: 2345839
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Blinded Sample Size Recalculation in Longitudinal Clinical Trials Using Generalized Estimating Equations.
    Wachtlin D; Kieser M
    Ther Innov Regul Sci; 2013 Jul; 47(4):460-467. PubMed ID: 30235527
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Some challenges with statistical inference in adaptive designs.
    Hung HM; Wang SJ; Yang P
    J Biopharm Stat; 2014; 24(5):1059-72. PubMed ID: 24915027
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Sample-size redetermination for repeated measures studies.
    Zucker DM; Denne J
    Biometrics; 2002 Sep; 58(3):548-59. PubMed ID: 12229989
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Sample size determination with a pilot study.
    O'Neill B
    PLoS One; 2022; 17(2):e0262804. PubMed ID: 35167592
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Sample size determination in superiority clinical trials with multiple co-primary correlated endpoints.
    Sozu T; Sugimoto T; Hamasaki T
    J Biopharm Stat; 2011 Jul; 21(4):650-68. PubMed ID: 21516562
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Aspects of sample size determination and power calculation illustrated on examples from rehabilitation research].
    Kutschmann M; Bender R; Grouven U; Berg G
    Rehabilitation (Stuttg); 2006 Dec; 45(6):377-84. PubMed ID: 17123220
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Variance estimation in clinical studies with interim sample size re-estimation.
    Miller F
    Biometrics; 2005 Jun; 61(2):355-61. PubMed ID: 16011681
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Blinded sample size reestimation in non-inferiority trials with binary endpoints.
    Friede T; Mitchell C; Müller-Velten G
    Biom J; 2007 Dec; 49(6):903-16. PubMed ID: 17726715
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Sample size determination in group-sequential clinical trials with two co-primary endpoints.
    Asakura K; Hamasaki T; Sugimoto T; Hayashi K; Evans SR; Sozu T
    Stat Med; 2014 Jul; 33(17):2897-913. PubMed ID: 24676799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.